These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 7514304)
1. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Eris JM; Basten A; Brink R; Doherty K; Kehry MR; Hodgkin PD Proc Natl Acad Sci U S A; 1994 May; 91(10):4392-6. PubMed ID: 7514304 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. Cooke MP; Heath AW; Shokat KM; Zeng Y; Finkelman FD; Linsley PS; Howard M; Goodnow CC J Exp Med; 1994 Feb; 179(2):425-38. PubMed ID: 8294858 [TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669 [TBL] [Abstract][Full Text] [Related]
4. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical. Kanost D; McCluskey J Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133 [TBL] [Abstract][Full Text] [Related]
5. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. Fulcher DA; Lyons AB; Korn SL; Cook MC; Koleda C; Parish C; Fazekas de St Groth B; Basten A J Exp Med; 1996 May; 183(5):2313-28. PubMed ID: 8642340 [TBL] [Abstract][Full Text] [Related]
6. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R J Exp Med; 2003 Apr; 197(7):845-60. PubMed ID: 12668643 [TBL] [Abstract][Full Text] [Related]
7. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. Ho WY; Cooke MP; Goodnow CC; Davis MM J Exp Med; 1994 May; 179(5):1539-49. PubMed ID: 7909325 [TBL] [Abstract][Full Text] [Related]
8. Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance. Yule TD; Basten A; Allen PM J Immunol; 1993 Sep; 151(6):3057-69. PubMed ID: 8376768 [TBL] [Abstract][Full Text] [Related]
9. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232 [TBL] [Abstract][Full Text] [Related]
10. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. Cook MC; Basten A; Fazekas de St Groth B J Exp Med; 1997 Aug; 186(5):631-43. PubMed ID: 9271579 [TBL] [Abstract][Full Text] [Related]
11. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850 [TBL] [Abstract][Full Text] [Related]
12. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849 [TBL] [Abstract][Full Text] [Related]
13. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947 [TBL] [Abstract][Full Text] [Related]
14. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. Snider DP; Segal DM J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743 [TBL] [Abstract][Full Text] [Related]
15. Reduced life span of anergic self-reactive B cells in a double-transgenic model. Fulcher DA; Basten A J Exp Med; 1994 Jan; 179(1):125-34. PubMed ID: 8270860 [TBL] [Abstract][Full Text] [Related]
16. Rescue of self-reactive B cells by provision of T cell help in vivo. Cook MC; Basten A; Fazekas de St Groth B Eur J Immunol; 1998 Aug; 28(8):2549-58. PubMed ID: 9710232 [TBL] [Abstract][Full Text] [Related]
17. Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors. Feuerstein N; Shivers D; Chen F; Eisenberg RA; Finkel TH Int Immunol; 2003 Aug; 15(8):975-85. PubMed ID: 12882835 [TBL] [Abstract][Full Text] [Related]